72730-0202 TRUSELTIQ - CanMED: NDC

Return Home

Home

SEER Data & Software

Observational Research in Oncology Toolbox

Product Information

CanMED: NDC

Product NDC:

72730-0202

Brand Name:

TRUSELTIQ

Generic Name:

infigratinib

Dosage Form Name:

CAPSULE

Administration Route:

Oral

Substances:

Name: INFIGRATINIB

Strength: 75.0

Unit: mg/1

Packages:

Code: 72730-0202-01

Description: 1 BLISTER PACK in 1 CARTON (72730-202-01) / 63 CAPSULE in 1 BLISTER PACK

Effective Date: May 28, 2021

Discontinued:

SEER*Rx Category:

Chemotherapy

Major Class:

Tyrosine Kinase Inhibitor

Minor Class:

FGFR

Orphan Drug Designation:

Status:

In Use